Moderators: Kelly Schlendorf, MD and Jignesh K. Patel, MD, PhD
Welcome and Program Panel Introduction
Kelly Schlendorf, MD, Vanderbilt University, Nashville, TN, USA
(268) Successful Transplantation of 96 Hepatitis C-positive Donor Hearts in the Era of Direct-Acting Antiviral Therapies
Kelly Schlendorf, MD, Vanderbilt University, Nashville, TN, USA
(269) HCV Seropositive Donors Positively Impact Heart Transplantation Rates and Waitlist Mortality without Compromising Outcomes
Peter J. Altshuler, MD, University of Pennsylvania, Philadelphia, PA, USA
(270) Intermediate Survival Outcomes after Heart Transplantation Using Donor HCV NAT Positive Hearts
Jonathan Nattiv, MD, University of Southern California, Los Angeles, CA, USA
(271) Outcomes of Heart Transplantation from Hepatitis C Seropositive Donors: An Updated Analysis of the United Network for Organ Sharing Registry
Selena S. Li, MD, Massachusetts General Hospital, Boston, MA, USA
(272) Magnitude of Viremia after Heart and Lung Transplantation from HCV Viremic Donors and Time to Clearance Based on Timing of Starting Therapy Post-Transplantation
Stacey Chen, MD, NYU Langone Health, New York, NY, USA
(273) Incidence of Acute Cellular Rejection in Heart Transplant Recipients from Hepatitis C Viremic Donors -- One-Year Follow-Up
Maxine W. Stachel, MD, NYU Langone Health, New York, NY, USA
(274) Cardiac Allograft Vasculopathy in Heart Transplant Recipients from Hepatitis C Viremic Donors
Bernard Kadosh, MD, NYU Langone Health, New York, NY, USA
Moderated Q & A Segment with All Presenters
Led by Jignesh K. Patel, MD, PhD, Cedars-Sinai Heart Institute, Beverly Hills, CA, USA
ISHLT Advanced Heart Failure and Transplantation Interdisciplinary Network Update
Marta Farrero Torres, MD, PhD, Hospital Clinic de Barcelona, Barcelona, Spain
Chair, ISHLT Advanced Heart Failure and Transplantation Interdisciplinary Network Steering Committee
ISHLT Announcements
Greg Schultz, CEO, ISHLT, Addison, TX, USA
Continuing Education Information
Learning Objectives – At the conclusion of this webinar attendees will increase the knowledge, performance and/or practice by listening to seven (7) abstracts that were to be presented at the 2020 ISHLT Scientific Annual Meeting. The presenters will be disseminating data as it relates to Hepatitis C+ Donors for Heart Transplantation: Redefining High Risk. Abstract presentations have been peer reviewed.
Target Audience – The target audience for the October Plenary Session includes physicians, surgeons, scientists, pharmacists, nurses, transplant coordinators and other allied health and social science professionals engaged in the management and treatment of patients with advanced heart or lung disease, basic science or clinical research related to these fields, or other specialties which cause them to become involved in the treatment of patients with advanced heart or lung disease.
Activity Designed to Change – This activity is designed to change knowledge, competence and performance.
Learning Attributes Patient Care and Medical Knowledge
Disclosures – Current guidelines state that participants in continuing medical and allied health professional education activities must be made aware of any affiliation or financial interest that may affect the program content or a speaker’s presentation. Planners, Faculty and Chairs participating in this meeting are required to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation or service as Chair/Planner. Disclosures will be distributed in the Learner Notification that you receive as a participant prior to the live virtual session. Additionally, all speakers have been asked to verbally disclose at the start of their presentation any financial interest or affiliations and to indicate if a product they are discussing is not labeled for the use under discussion or is still investigational.
Disclaimer – The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the ISHLT.
Documenting CME Credits – The ISHLT provides CME certificates to those who have participated in an ISHLT educational activity. The ISHLT does not submit credits to regulating bodies or certifying organizations on behalf of the participants. It is the participants responsibility to submit proof of credits on his or her own behalf.
ACCME Accreditation
Physicians
Accreditation Statement - The International Society for Heart and Lung Transplantation (ISHLT) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement – ISHLT designates this live virtual activity for a maximum of
1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and The International Society for Heart and Lung Transplantation (ISHLT). Amedco LLC is jointly accredited by the American Council for Continuing Medical Education (ACCME) the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1.5 contact hours for nurses.
Amedco LLC has submitted an application to the Accreditation Council for Pharmacy Education (ACPE) for continuing education credits for this activity.
Note to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education.
Transplant Coordinators Credit
An application has been submitted to the
American Board for Transplant Certification for Continuing Education Points for this offering.